HCPCS code J3397 — Inj., vestronidase alfa-vjbk. Status: Active. Effective Jan 1, 2024. Source: CMS HCPCS Level II.

J3397

Active

Inj., vestronidase alfa-vjbk

Injection, vestronidase alfa-vjbk, 1 mg

Category: Drugs
Section: J-codes: Drugs Administered Other Than Oral Method
Effective: Jan 1, 2024
Code type: alphanumeric
OPPS Status: K — Non-pass-through drugs and biologicals
OPPS APC: 9190

MUE — Medically Unlikely Edits

Maximum units of J3397 Medicare will pay for one beneficiary on one date of service. Claims exceeding the MUE are denied or returned for review.

Service Type Max Units / Day
Outpatient Hospital 600
Practitioner Services 600

Source: CMS Medicare NCCI Medically Unlikely Edits

Change History

Quarterly changes published by CMS. Revisions may affect the code description, coverage, or rate — review each quarter's changes before submitting claims.

  • New Code 2024-Q1
    Inj., vestronidase alfa-vjbk